Author details

Full Name

Marianne S Muhlebach

Affiliation

ORCID

Career Start Year

1999

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36675409	Airway Findings in Patients with Hunter Syndrome Treated with Intravenous Idursulfase.		2023
37953182	Association of Pseudomonas aeruginosa incident infections with adherence to cystic fibrosis foundation care guidelines.		2023
36519944	Antibiotic Tolerance and Treatment Outcomes in Cystic Fibrosis Methicillin-Resistant Staphylococcus aureus Infections.		2023
36902441	Revisiting Host-Pathogen Interactions in Cystic Fibrosis Lungs in the Era of CFTR Modulators.		2023
34456157	Longitudinal changes and regional variation of incident infection rates at cystic fibrosis centers, United States 2010-2016.	Journal of Cystic Fibrosis	2022
35963814	Predicting risk-adjusted incidence rates of methicillin-resistant Staphylococcus Aureus and Pseudomonas Aeruginosa in cystic fibrosis programs in the United States.	Journal of Cystic Fibrosis	2022
35437233	Mucus and mucus flake composition and abundance reflect inflammatory and infection status in cystic fibrosis.	Journal of Cystic Fibrosis	2022
35486871	Cystic Fibrosis Airway Mucus Hyperconcentration Produces a Vicious Cycle of Mucin, Pathogen, and Inflammatory Interactions that Promotes Disease Persistence.	American Journal of Respiratory Cell and Molecular Biology	2022
36511181	Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.		2022
36478917	Eradication of early MRSA infection in cystic fibrosis: a novel study design for the STAR-ter trial.	ERJ Open Res	2022
34521595	Barriers implementing infection prevention and control experienced by healthcare workers, people with CF and parents.	Journal of Cystic Fibrosis	2022
34646879	Impact of the SARS-CoV-2 pandemic on cystic fibrosis centres and care: survey results from US centres.	ERJ Open Res	2021
34103251	Phenotypic characteristics of incident and chronic MRSA isolates in cystic fibrosis.	Journal of Cystic Fibrosis	2021
32563724	Antimicrobial resistance: Concerns of healthcare providers and people with CF.	Journal of Cystic Fibrosis	2021
34667993	ATS Core Curriculum 2021. Pediatric Pulmonary Medicine: Pulmonary Infections.	ATS Sch	2021
32573948	Highlights from the 2019 North American Cystic Fibrosis Conference.	Pediatric Pulmonology	2020
32122785	Finding the relevance of antimicrobial stewardship for cystic fibrosis.	Journal of Cystic Fibrosis	2020
31870630	Utilizing centralized biorepository samples for biomarkers of cystic fibrosis lung disease severity.	Journal of Cystic Fibrosis	2020
31390877	Chronic E-Cigarette Use Increases Neutrophil Elastase and Matrix Metalloprotease Levels in the Lung.	American Journal of Respiratory and Critical Care Medicine	2019
32812947	Metabonomics reveals altered metabolites related to inflammation and energy utilization at recovery of cystic fibrosis lung exacerbation.		2019
31091021	Highlights from the 2018 North American cystic fibrosis conference.	Pediatric Pulmonology	2019
31036402	Cystic fibrosis program characteristics associated with adoption of 2013 infection prevention and control recommendations.	American Journal of Infection Control	2019
30905581	Assessment of stability and fluctuations of cultured lower airway bacterial communities in people with cystic fibrosis.	Journal of Cystic Fibrosis	2019
29655374	Surveying Cystic Fibrosis Care Centers to Assess Adoption of Infection Prevention and Control Recommendations.	Infection Control and Hospital Epidemiology	2018
30073802	Biology and management of methicillin resistant Staphylococcus aureus in cystic fibrosis.	Pediatric Pulmonology	2018
30030966	Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.		2018
30351435	Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patients.	Journal of Antimicrobial Chemotherapy	2018
29968973	Tracheostomy in children: Epidemiology and clinical outcomes.	Pediatric Pulmonology	2018
29946004	Anaerobic bacteria cultured from cystic fibrosis airways correlate to milder disease: a multisite study.	European Respiratory Journal	2018
29346420	Initial acquisition and succession of the cystic fibrosis lung microbiome is associated with disease progression in infants and preschool children.	PLoS Pathogens	2018
29661528	Meropenem time above the MIC exposure is predictive of response in cystic fibrosis children with acute pulmonary exacerbations.	Diagnostic Microbiology and Infectious Disease	2018
29660839	Highlights from the 2017 North American Cystic Fibrosis Conference.	Pediatric Pulmonology	2018
27852955	Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial.	Thorax	2017
28796008	Methicillin-resistant Staphylococcus aureus in cystic fibrosis: how should it be managed?	Current Opinion in Pulmonary Medicine	2017
28696526	Highlights from the 2016 North American Cystic Fibrosis Conference.	Pediatric Pulmonology	2017
27550351	Population Pharmacokinetics and Safety of Ceftolozane-Tazobactam in Adult Cystic Fibrosis Patients Admitted with Acute Pulmonary Exacerbation.	Antimicrobial Agents and Chemotherapy	2016
26774156	Production of extended-spectrum Î²-lactamases and the potential indirect pathogenic role of Prevotella isolates from the cystic fibrosis respiratory microbiota.	International Journal of Antimicrobial Agents	2016
27074261	Highlights from the 2015 North American Cystic Fibrosis Conference.	Pediatric Pulmonology	2016
26416780	Population pharmacokinetics of meropenem administered as a prolonged infusion in children with cystic fibrosis.	Journal of Antimicrobial Chemotherapy	2016
27707435	Progression of Polysomnographic Abnormalities in Mucolipidosis II (I-Cell Disease).	Journal of Clinical Sleep Medicine	2016
28215711	Biomarkers for cystic fibrosis drug development.	Journal of Cystic Fibrosis	2016
27836957	Metabolomic biomarkers predictive of early structural lung disease in cystic fibrosis.	European Respiratory Journal	2016
26336603	Outcomes and Treatment of Chronic Methicillin-Resistant Staphylococcus aureus Differs by Staphylococcal Cassette Chromosome mec (SCCmec) Type in Children With Cystic Fibrosis.	Journal of the Pediatric Infectious Diseases Society	2015
25927091	Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.		2015
25745825	Multicenter Observational Study on Factors and Outcomes Associated with Various Methicillin-Resistant Staphylococcus aureus Types in Children with Cystic Fibrosis.	Annals of the American Thoracic Society	2015
26266556	The Role of Short-Chain Fatty Acids, Produced by Anaerobic Bacteria, in the Cystic Fibrosis Airway.	American Journal of Respiratory and Critical Care Medicine	2015
26003469	Microbiological activity of ceftolozane/tazobactam, ceftazidime, meropenem, and piperacillin/tazobactam against Pseudomonas aeruginosa isolated from children with cystic fibrosis.	Diagnostic Microbiology and Infectious Disease	2015
26542299	Lessons learned from metabolomics in cystic fibrosis.	Molecular and Cellular Pediatrics	2015
24917582	Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patients.	Journal of Antimicrobial Chemotherapy	2014
23765686	Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis.	Pediatric Pulmonology	2014